Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?

J Clin Oncol. 2015 Apr 10;33(11):1298-9. doi: 10.1200/JCO.2014.59.7286. Epub 2015 Mar 9.

Authors

Alberto Ocaña¹, Laura Diez-Gónzález², Encarna Adrover², Antonio Fernández-Aramburo², Atanasio Pandiella³, Eitan Amir⁴

Affiliations

¹ Albacete University Hospital, Albacete, Spain albertoo@sescam.jccm.es.
² Albacete University Hospital, Albacete, Spain.
³ Instituto de Biología Molecular y Celular del Cancer-Centro Superior de Investigaciones Científicas, Universidad de Salamanca, Salamanca, Spain.
⁴ Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

PMID: 25753437
DOI: 10.1200/JCO.2014.59.7286

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / analysis*
Female
Humans
Lymphocytes, Tumor-Infiltrating*
Triple Negative Breast Neoplasms / pathology*

Substances

Biomarkers, Tumor